High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes: application to measurement of dihydropyrimidine dehydrogenase activity-Reference-Cited by-同舟云学术

High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes: application to measurement of dihydropyrimidine dehydrogenase activity

Published:2001-10 Issue:2 Volume:762 Page:203-209
ISSN:0378-4347
Container-title:Journal of Chromatography B: Biomedical Sciences and Applications
language:en
Short-container-title:Journal of Chromatography B: Biomedical Sciences and Applications

Author:

Déporte-Féty R.,Picot M.,Amiand M.,Moreau A.,Campion L.,Lanoë D.,Renée N.,Milano G.

Publisher

Elsevier BV

Subject

General Chemistry

Reference14 articles.

1. Clinical Pharmacology of 5-Fluorouracil

2. Influence of sex and age on fluorouracil clearance.

3. Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy.

4. Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure;Pharmaceuticals;2020-11-23

2. Towards Rational Cancer Therapeutics: Optimizing Dosing, Delivery, Scheduling, and Combinations;Clinical Pharmacology & Therapeutics;2020-08-02

3. A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficiency in Patients With Cancer;Clinical and Translational Science;2020-04-07

4. Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency;Pharmacogenomics;2019-08

5. Monitoring of the 5-FU therapy: Safety and efficacy of treatment?;Postępy Higieny i Medycyny Doświadczalnej;2018-03-02